ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Natco Pharma proposes to acquire Dash Pharmaceuticals
According to a press release issued by the Hyderabad-based drug maker, Dash is a front-end pharmaceutical sales, marketing and distribution entity based in New Jersey, USA which is expected to have approximate net sales of USD 15 million for the year endin
Announcement as on 14 December 2021

Natco Pharma launches novel fixed-dose combination drug for colorectal, gastric cancer
Natco Pharma has launched a novel fixed-dose combination of Trifluridine and Tipiracil, used to treat advanced colorectal and gastric cancer, in the country. The company has launched the product under the brand name Tipanat in a pack of 20 tablets in a bot
Announcement as on 18 November 2021

Natco Pharma launches novel drug for colorectal, gastric cancer
Natco Pharma on Thursday said it has launched a novel fixed-dose combination of Trifluridine and Tipiracil, used to treat advanced colorectal and gastric cancer, in the country. The company has launched the product under the brand name Tipanat in a pack of
Announcement as on 18 November 2021

Natco Pharma, Hetero seek marketing authorisation for anti-Covid drug molnupiravir
​Natco has conducted Phase III trials of molnupiravir and submitted the trial results to the drug regulator this month. ​"We have submitted phase-III clinical trial results of Molnupiravir to DCGI and we are awaiting for their marketing permission,”
Announcement as on 28 October 2021

Dr Reddy's, Natco Pharma launch generic cancer drug in Canada
Dr Reddy's Laboratories and Natco Pharma on Thursday said they have launched generic capsules used in the treatment of multiple myeloma and myelodysplastic syndrome patients in the Canadian market.
Announcement as on 02 September 2021

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 886.96
  • 12Day Average: 904.36
  • 20Day Average: 912.71
  • 50Day Average: 918.65
  • 100Day Average: 997.18
  • 150Day Average: 964.28
  • 200Day Average: 943.1

524816 Indicators & signals

Indicator MACD (12,26,9)

901.16, 915.18, -10.8
Indicator MACD is in negative zone

Indicator ADX (14)

6.56, 20.42, 17.91
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 47
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
21 Fri Aug 2026 882.50 877.95 to 900.00 0.54% 0.74 times
20 Thu Aug 2026 877.75 875.30 to 894.30 -1.05% 0.68 times
19 Wed Aug 2026 887.05 883.10 to 916.60 -1.2% 0.29 times
18 Tue Aug 2026 897.80 889.70 to 900.10 0.91% 0.37 times
17 Mon Aug 2026 889.70 870.70 to 898.85 -1.41% 1.2 times
14 Fri Aug 2026 902.40 885.75 to 962.25 -5.23% 3.7 times
13 Thu Aug 2026 952.25 917.60 to 960.40 4.07% 1.64 times
12 Wed Aug 2026 915.00 906.00 to 922.00 0.89% 0.48 times
11 Tue Aug 2026 906.90 903.55 to 929.40 -0.5% 0.77 times
10 Mon Aug 2026 911.50 905.55 to 932.00 -0.62% 0.73 times
07 Fri Aug 2026 917.15 912.00 to 921.10 0.53% 0.14 times
06 Thu Aug 2026 912.35 910.00 to 932.75 -0.58% 0.75 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top